semaglutide fda approved for weight loss US approves drug Wegovy to prevent cardiovascular events US FDA accepts Novo Nordisk's

Use gentle cleansing and avoid rubbing or irritating the area after injection

Discounted pricing at higher doses requires refilling within 45 days of the prior delivery

Average weight loss: 19.7% at 48 weeks A1C reduction: 2.02% (from 8.1% to 6.08%) Success rate for A1C under 7.0%: 87% Success rate for A1C under 6.5%: 71% The 87% success rate for achieving A1C under 7.0% warrants particular attention

or overweight if their BMI is greater than 27 accompanied by weight-related medical problems such as high blood pressure, type 2 diabetes, or high cholesterol

I knowthats probably not what you were hoping to hear